New commercial highlights the abilities of IBM Watson Genomics from Quest Diagnostics for clinicians and patients, no matter where they are.
IBM Watson Genomics from Quest Diagnostics combines genomic sequencing expertise with Watson-powered cognitive computing to inform precision treatment and clinical trial options for cancer patients.
Prostate cancer is the seconding leading cause of cancer death in U.S. men, but if diagnosed early, the five-year survival rate is almost 100 percent.
Data sharing is emerging as an important part of cancer diagnosis and treatment, and is even an imperative of Vice President Biden’s Cancer Moonshot program.
When organizations pool their BRCA data, they are better positioned to discover new information on BRCA genes and, in turn, enhance patient testing.